PAXIP1 and central nervous system cancer: Kaplan-Meier analysis of the association between lncRNA PAXIP1-AS1 expression and survival of glioma patients (Fig. 1d) revealed that the overall survival of glioma patients with high lncRNA PAXIP1-AS1 expression was lower than that in patients with low lncRNA PAXIP1-AS1 expression (p < 0.05).